Pharmacological Therapy of Benign Prostate Syndrome

    December 2015 in “ Der Urologe ”
    M. Oelke, Evangelista Martinelli
    Studysummary Combining medications is more effective for treating benign prostatic syndrome symptoms.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on link.springer.com →
    Discuss this study in the Community →

    Research cited in this study 2

    1. The Long-Term Effect of Doxazosin, Finasteride, and Combination Therapy on the Clinical Progression of Benign Prostatic Hyperplasia The New England Journal of Medicine · 2003
    2. Pharmacological Treatment of Benign Prostatic Syndrome with Alpha1-Receptor Blockers: Basics and Clinical Results Der Urologe · 2002

    Related research 5

    1. 5-Alpha Reductase Inhibitors in Androgenetic Alopecia: Shifting Paradigms, Current Concepts, Comparative Efficacy, and Safety Dermatologic Therapy · 2020
    2. What Do We Know About 5-Alpha Reductase Inhibitors? Surgical and Cosmetic Dermatology · 2018
    3. Atypical Post-Finasteride Syndrome: A Pharmacological Riddle Indian Journal of Pharmacology · 2016
    4. Comparison of Clinical Efficacy of Finasteride and Dutasteride as 5-Alpha Reductase Inhibitors Daehan namseong gwahag hoeji · 2012
    5. 5 Alpha-Reductase Inhibitors: What's New? Current opinion in urology · 2003